nintedanib 100 MG Oral Capsule
- RxCUI
- 1592742
- RxNorm name
- nintedanib 100 MG Oral Capsule
- Display name
- nintedanib 100 MG Oral Capsule
- Full name
- nintedanib 100 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nintedanib | NINTEDANIB | Edenbridge Pharmaceuticals LLC. | 43dae004-eaf6-4411-8c3d-db7ab2c3b41e | 2026-07-29 | Warnings, Adverse reactions | 1592742 |
| nintedanib | NINTEDANIB | AvKARE | 572722d7-338a-e4d2-e063-6394a90a257c | 2026-07-21 | Warnings, Adverse reactions | 1592742 |
| nintedanib | NINTEDANIB | Glenmark Pharmaceuticals Inc., USA | b14164fb-0276-4ad1-a5ff-400ab9e292da | 2026-07-10 | Warnings, Adverse reactions | 1592742 |
| nintedanib | NINTEDANIB | EPIC PHARMA LLC | 0e12f080-fcb4-465f-b988-4fa2c79f49aa | 2026-07-09 | Warnings, Adverse reactions | 1592742 |
| Nintedanib | NINTEDANIB | Golden State Medical Supply, Inc. | 4ecf7f05-4a95-b98c-e063-6394a90ab896 | 2026-06-16 | Warnings, Adverse reactions | 1592742 |
| Nintedanib Capsules, 100 mg and 150 mg | NINTEDANIB | EXELAN PHARMACEUTICALS INC. | 60d8104e-cb6c-4f4f-8159-95ed57346ffa | 2026-04-21 | Warnings, Adverse reactions | 1592742 |
| Nintedanib | NINTEDANIB | Cipla USA Inc. | 4d017c42-a823-452d-bc6f-0491dd9823e3 | 2026-04-02 | Warnings, Adverse reactions | 1592742 |
| Nintedanib | NINTEDANIB | Apotex Corp. | b72b26c3-7731-80c0-734b-a5f53a1d89ae | 2026-03-20 | Warnings, Adverse reactions | 1592742 |
| nintedanib | NINTEDANIB | Sandoz Inc | 751c3473-35d6-47d6-b405-af16a989716c | 2026-01-20 | Warnings, Adverse reactions | 1592742 |
| Nintedanib | NINTEDANIB | Dr. Reddy's Laboratories Inc. | 88f8600d-0974-51ca-6f8e-28c48a379e08 | 2025-11-20 | Warnings, Adverse reactions | 1592742 |
| Ofev | NINTEDANIB | Boehringer Ingelheim Pharmaceuticals, Inc. | da1c9f37-779e-4682-816f-93d0faa4cfc9 | 2025-11-20 | Warnings, Adverse reactions | 1592742 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| da1c9f37-779e-4682-816f-93d0faa4cfc9 | nintedanib 100 MG Oral Capsule | PSN | 21 | These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 2014 | 20251120 |
| da1c9f37-779e-4682-816f-93d0faa4cfc9 | nintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule | SY | 21 | These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 2014 | 20251120 |
| da1c9f37-779e-4682-816f-93d0faa4cfc9 | nintedanib 100 MG Oral Capsule | SCD | 21 | These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 2014 | 20251120 |
| 88f8600d-0974-51ca-6f8e-28c48a379e08 | nintedanib 100 MG Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20251120 |
| 88f8600d-0974-51ca-6f8e-28c48a379e08 | nintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule | SY | 4 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20251120 |
| 88f8600d-0974-51ca-6f8e-28c48a379e08 | nintedanib 100 MG Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20251120 |
| 4d017c42-a823-452d-bc6f-0491dd9823e3 | nintedanib 100 MG Oral Capsule | PSN | 3 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260402 |
| 4d017c42-a823-452d-bc6f-0491dd9823e3 | nintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule | SY | 3 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260402 |
| 4d017c42-a823-452d-bc6f-0491dd9823e3 | nintedanib 100 MG Oral Capsule | SCD | 3 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260402 |
| 43dae004-eaf6-4411-8c3d-db7ab2c3b41e | nintedanib 100 MG Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260415 |
| 43dae004-eaf6-4411-8c3d-db7ab2c3b41e | nintedanib 100 MG Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260415 |
| 43dae004-eaf6-4411-8c3d-db7ab2c3b41e | nintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule | SY | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260415 |
| 751c3473-35d6-47d6-b405-af16a989716c | nintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule | SY | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260120 |
| 751c3473-35d6-47d6-b405-af16a989716c | nintedanib 100 MG Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260120 |
| 751c3473-35d6-47d6-b405-af16a989716c | nintedanib 100 MG Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260120 |
| 60d8104e-cb6c-4f4f-8159-95ed57346ffa | nintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule | SY | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260421 |
| 60d8104e-cb6c-4f4f-8159-95ed57346ffa | nintedanib 100 MG Oral Capsule | SCD | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260421 |
| 60d8104e-cb6c-4f4f-8159-95ed57346ffa | nintedanib 100 MG Oral Capsule | PSN | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260421 |
| 4ecf7f05-4a95-b98c-e063-6394a90ab896 | nintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule | SY | 1 | NINTEDANIB CAPSULES. These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260406 |
| 4ecf7f05-4a95-b98c-e063-6394a90ab896 | nintedanib 100 MG Oral Capsule | PSN | 1 | NINTEDANIB CAPSULES. These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260406 |
| 4ecf7f05-4a95-b98c-e063-6394a90ab896 | nintedanib 100 MG Oral Capsule | SCD | 1 | NINTEDANIB CAPSULES. These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260406 |
| b72b26c3-7731-80c0-734b-a5f53a1d89ae | nintedanib 100 MG Oral Capsule | PSN | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260320 |
| b72b26c3-7731-80c0-734b-a5f53a1d89ae | nintedanib 100 MG Oral Capsule | SCD | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260320 |
| b72b26c3-7731-80c0-734b-a5f53a1d89ae | nintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule | SY | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260320 |